Epalrestat

Specifications

82159-09-9CAS Number

675-018-0EC Number

2-[(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acidIUPAC Name

C15H13NO3S2Chemical Formula

319.4 g/molMolecular Weight

epalrestat; 82159-09-9; Kinedak; Epalrestatum; Ono-2235; Ono 2235; Aldonil; Aldorin; Tanglin; ONO-2; 2-[(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid; 5-((1Z,2E)-2-Methyl-3-phenylpropenylidene)-4-oxo-2-thioxo-3-thiazolidineacetic acid; 424DV0807X; 5-((Z,E)-beta-Methylcinnamylidene)-4-oxo-2-thioxo-3-thiazolidineacetic acid; CHEBI:31539; 2-[(5Z)-5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid; 3-Thiazolidineacetic acid, 5-(2-methyl-3-phenyl-2-propenylidene)-4-oxo-2-thioxo-, (E,E)-; DTXSID1046479; 2-((5Z)-5-((2E)-2-methyl-3-phenylprop-2-en-1-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)acetic acid; 2-((5Z)-5-((E)-2-methyl-3-phenylprop-2-enylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)acetic acid; 3-carboxymethyl-5-(methyl-3-phenylpropenylidene)rhodanine; RefChem:590902; DTXCID60210103; 2-((5Z)-5-((2E)-2-Methyl-3-phenylprop-2-en-1-ylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid; 675-018-0; Epalrestat [INN]; 2-((z)-5-((e)-2-methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid; MFCD00865484; CHEMBL56337; C15H13NO3S2; {(5Z)-5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic acid; Epalrestatum [Latin]; {5-[(E)-2-Methyl-3-phenyl-prop-2-en-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-acetic acid; 2-[5-(2-methyl-3-phenylprop-2-en-1-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid; ONO 2; Kinedak (TN); ONO2235; Ropestatin;; UNII-424DV0807X; (Z,Z)-5-(2-Methyl-3-phenyl-propenylidene)-4-oxo-2-thioxo-3-thiazolidineacetic Acid; NCGC00164613-01; 2-[5-((2E)-2-methyl-3-phenylprop-2-enylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3 -yl]acetic acid; Epalrestat (Standard); 5-[(1Z, 2E)-2-methyl-3-phenylpropenylidene]-4-oxo2-thioxo-3-thiazolidineacetic acid; EPALRESTAT [MI]; EPALRESTAT [JAN]; Epalrestat (JP18/INN); EPALRESTAT [MART.]; EPALRESTAT [WHO-DD]; MLS000806985; Epalrestat - Bio-X trade mark; orb1308563; SCHEMBL1649205; GTPL11371; CHNUOJQWGUIOLD-NFZZJPOKSA-N; REGID_for_CID_1549120; HMS2747M09; HMS3887A17; HMS5087N15; BDBM50049730; HY-66009R; s2035; SBB015450; STK337187; AKOS000274207; CCG-267693; DB15293; FE22700; NCGC00164613-06; NCGC00164613-08; NCGC00164613-12; (5Z)-5-[(2E)-2-Methyl-3-phenyl-2-propen-1-ylidene]-4-oxo-2-thioxo-3-thiazolidineacetic Acid; AS-13345; BE164412; HY-66009; SMR000414799; SY051251; E0906; ST50054938; SW219826-1; D01688; SBI-0653900.0001; AB00647195_06; F036565; Q5382029; BRD-K98054437-001-08-1; BRD-K98054437-001-09-9; BRD-K98054437-001-11-5; [5-(2-Methyl-3-phenyl-allylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-acetic acid; 2-(5-(2-methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid; 5-((Z,E)-.BETA.-METHYLCINNAMYLIDENE)-4-OXO-2-THIOXO-3-THIAZOLIDINEACETIC ACID; (5-[(e)-2-methyl-3-phenyl-prop-2-en-(z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl)-acetic acid 82159-; {(5Z)-5-[(2E)-2-Methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}acetic acid; 2-[(5Z)-5-[(E)-2-methyl-3-phenyl-prop-2-enylidene]-4-oxo-2-thioxo-thiazolidin-3-yl]acetic acid; 2-[(5Z)-5-[(E)-3-phenil-2-methylprop-2-enylidene]-4-oxo-2-thioxo-3-thiazolidinyl]acetic acidSynonyms